The global Genome
Editing Market share report provides numbers for applications and
regional segments of the industry covering historical as well as forecast data
for decision makers.
Global Market
Insights, Inc. says, Genome editing industry value, worth USD 2.17 billion in
2015, is set to hit USD 7.5 billion by 2024.
Genome editing market revenue is
anticipated to witness a notable surge over the years ahead, driven by the
escalating occurrence of cancer and other genetic inherited disorders coupled
with mounting demand for personalized medicines. Companies have been spending
extensively on R&D activities across the pharma & biotech sectors. In
addition, the availability of enhanced healthcare facilities and the
introduction of new modes of treatment will offer lucrative avenues for the
gene editing market players to expand their business.
Considering the geographical landscape,
U.S. genome editing market, worth USD 518.5 million in 2015, is slated to
expand considerably in the future. A strong growth trend displayed by
biotechnology and pharmaceutical firms is expected to boost the industry size.
UK genome editing industry is projected
to cross a revenue of USD 744 million by 2024, registering a CAGR of 14.9% over
2016-2024. The high occurrence of chronic disorders among the rising old
population will propel the industry development. Increasing occurrence of HIV,
hemophilia, and sickle cell anemia will spur the growth of South Africa
industry.
Japan genome editing market revenue,
worth USD 160 million in 2015, is projected to grow at a rate of 15% over the
coming timeframe. Improvement in healthcare amenities and favorable government
policies to restrict the spread of infectious diseases will push the business
expansion.
Browse
key industry insights spread across 150 pages with 90 market data tables &
7 figures & charts from this 2017 report Genome Editing Market in
detail along with the table of contents at:
Genome editing finds varied applications
in muscular disorders, hematology, oncology, and infectious ailments.
Hematology, which contributed USD 807 million towards gene editing industry
share in 2015, is expected to make notable contributions towards the industry
revenue even in the future. Oncology is set to record a CAGR of 15.9% over the
coming seven years, with the mounting occurrence of various kinds of cancers.
Biotech & pharma firms, contract
research organizations, and research institutes are the key end-users of genome
editing industry. Biotech & pharma sector, which accounted for more than
58% of gene editing market size in 2015, is expected to witness a substantial
surge over the next few years. Rising use of the technology in medicines and
therapeutics will boost the revenue.
Genome editing makes use of technologies
such as meganucleases, CRISPR/Cas9, TALENS, and zinc finger nucleases. CRISPR
technology, which dominated the overall market in 2015, is set to surpass USD 3
billion by 2024. The growth can be ascribed to wider applications of the
technology in farming and genetic engineering.
Bio Rad Laboratories Inc., Editas
Medicine, Sigma-Aldrich, Thermo Fisher Scientific, and Allele Biotechnology are
the major players of gene editing market.
Browse Related
Report:
Digital Genome Market Size By
Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits,
Sequencing Chips, Sequencing & Analysis Software, Sample Prep Instruments),
By Application (Microbiology [Biological, Clinical, Industrial], Reproductive
& Genetic, Transplantation, Livestock and Agriculture, Forensics, Research
and Development), By End-Use (Diagnostics & Forensic Labs, Academic
Research Institutes, Hospitals, Bio-pharmaceutical Companies), Industry
Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, Spain,
Russia, France, China, Japan, India, Australia, Argentina, Brazil, Mexico South
Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market
Share & Forecast, 2016 – 2024
About Fractovia.org:
Fractovia.org is one of India's leading in-house
and free news portal. It is fully automated, and operates on a constant
premise, interfacing with news sites and offering redesigned breaking features
to readers across the globe. Our mission is to offer individuals opportunities
for connections with news writers and distributors which they can pursue. We
operate by mapping articles pertaining to breaking news, constantly and
progressively, against a pre-determined word-based theme, offering important
connections to readers and clients, as well as distributors.
Contact
Us:
Arun Hegde
Corporate Sales, USA
Fractovia.org
Phone: 1-302-846-7766
Email: sales@fractovia.org
Web: https://www.fractovia.org
Contact Us: Facebook | Twitter
Corporate Sales, USA
Fractovia.org
Phone: 1-302-846-7766
Email: sales@fractovia.org
Web: https://www.fractovia.org
Contact Us: Facebook | Twitter
No comments:
Post a Comment